venBio


venBio is a life sciences investment firm focused on partnering with industry leaders to develop groundbreaking medicines and technologies. The firm emphasizes novel therapeutics for unmet medical needs, aiming to position its portfolio companies for success through strategic planning and expertise in clinical development.

venBio

venBio

1700 Owens Street, Suite 595, San Francisco, CA 94158


Portfolio

Developing therapies to block the CD47 checkpoint mechanism.

#Immuno-oncology

Developing therapies for NASH and other metabolic diseases.

#Biotechnology

Focused on therapies for rare neurological disorders.

#Pharmaceuticals

Developing cancer immunotherapy treatments.

#Biotechnology

Developing allogeneic NK cell therapies for cancer.

#Biotechnology

Pioneering targeted C3 therapies.

#Biopharmaceuticals

Developing targeted radiopharmaceuticals for cancer.

#Radiopharmaceuticals

Focused on treatments for systemic amyloidosis.

#Biopharmaceuticals

Advancing a pipeline of immune modulators for inflammatory diseases.

#Biotechnology

Developing oral bradykinin-B2-receptor antagonists for HAE.

#Biotechnology

Focused on precision oncology therapies.

#Biotechnology

Developing novel immunotherapies for cancer.

#Biopharmaceuticals

Developing CAR T-cell therapies for cancer.

#Biotechnology

Developing a novel biparatopic nanobody platform.

#Biotechnology

Engineering antibody-based radiopharmaceuticals for cancer.

#Radiopharmaceuticals